Kansas City

Kansas City, Missouri 64131

0 studies enrolling now · 1 studies all time

What they study most

Cirrhosis, Non-alcoholic Steatohepatitis, Portal Hypertension

Studies at this site

• Emricasan, an Oral Caspase Inhibitor, in Subjects With NASH Cirrhosis and Severe Portal Hypertension — Completed